Bold claim: Huawei is expanding a breakthrough health feature to the Watch GT 6 Pro, letting users gauge heart failure risk right from their wrist. But here’s where it gets interesting: this capability first appeared on the Watch Ultimate 2 in January, and now it’s expanding to another high-end model.
Huawei’s Watch GT 6 Pro sits at the top of the lineup, boasting premium touches like sapphire glass and an aerospace-grade titanium alloy chassis. It’s powered by a 1.47-inch AMOLED display that reaches up to 3000 nits in brightness, delivering a vivid, easily readable interface even in strong sunlight. A standout practical benefit is its impressive battery life: up to two weeks with typical use and up to 21 days in full power-saving mode.
The lineup originally shipped with HarmonyOS 6, featuring exclusive watch faces and a broadened suite of health features. The latest upgrade for the Watch GT 6 series, HarmonyOS 6.0.0.188, introduces the coronary heart failure risk assessment feature. To access it, users must participate in the coronary heart failure campaign via the Huawei Innovation Research app on their device.
How the heart failure risk feature works: it analyzes vital health data across different daytime and nighttime conditions. After about three to four days, users can view their coronary heart failure risk assessment results. Note that this feature is currently limited to the Chinese model.
Beyond the heart health enhancement, the update adds practical quality-of-life improvements: new settings to silence message notifications and smart reminders, expanded compatibility for remote camera control with more Android devices, and improved accuracy for open-water swimming distance. Users can also expect overall display and system stability improvements following the rollout.
In brief, Huawei’s Watch GT 6 Pro blends premium hardware with a gradually expanding health toolkit, delivering deeper health insights while maintaining strong everyday usability. This approach reflects Huawei’s broader strategy of weaving advanced wellness features into its flagship wearables, inviting ongoing discussion about accessibility, regional rollout, and the balance between medical-style metrics and consumer smartwatch data.
What do you think about bringing heart failure risk assessment to consumer wearables? Should such features be available globally, or remain limited by regional compliance and data considerations? Share your thoughts in the comments.
